{"id":788064,"date":"2026-02-02T12:13:01","date_gmt":"2026-02-02T12:13:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=788064"},"modified":"2026-02-02T12:13:01","modified_gmt":"2026-02-02T12:13:01","slug":"ocemida-nexis-ranks-highest-in-independent-hydrogen-water-bottle-testing","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/ocemida-nexis-ranks-highest-in-independent-hydrogen-water-bottle-testing_788064.html","title":{"rendered":"Ocemida Nexis Ranks Highest in Independent Hydrogen Water Bottle Testing"},"content":{"rendered":"
\n
\"Ocemida<\/a><\/div>\n
\n
Ocemida Nexis (6000-PRO)<\/div>\n<\/div>\n<\/div>\n
Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers alike<\/div>\n

Ocemida, a Canadian innovator in molecular hydrogen technology, today announced that its flagship Ocemida Nexis<\/strong> has achieved the highest hydrogen concentration recorded by H2Hubb for a portable device, based on independent laboratory testing.<\/p>\n

Using a high-precision Unisense H\u2082 laboratory sensor<\/strong>, standardized evaluation by H2Hubb confirmed that the Nexis reached 7.7 parts per million (ppm)<\/strong> of dissolved molecular hydrogen within a 10-minute cycle<\/strong>. The test report stated the device “tested extremely well”<\/em> and is “currently the highest hydrogen-performing bottle”<\/em> the organization can recommend.<\/p>\n

This result builds on Ocemida’s track record of third-party validation, having previously undergone independent evaluation by H2Analytics<\/strong>. Together, these assessments position the Ocemida Nexis as a leading option for consumers seeking verified performance, as well as researchers requiring reliable high-concentration hydrogen water.<\/p>\n

Performance You Can Verify<\/strong><\/p>\n

In an industry often characterized by aggressive wellness marketing, Ocemida distinguishes itself through transparency and independent verification rather than unsubstantiated claims.<\/p>\n

“We believe consumers deserve the same level of proof that researchers demand,” said Daniel, Founder of Ocemida. “Whether you’re studying molecular hydrogen or simply want to know your device actually performs as claimed, the data should speak for itself. That’s why we invest in third-party testing and make the results available.”<\/p>\n

Engineered for Everyone<\/strong><\/p>\n

The Ocemida Nexis utilizes advanced SPE\/PEM technology<\/strong> to ensure gas purity and device longevity. By consistently delivering 7.7 ppm – <\/strong>well above standard consumer hydrogen water devices – the Nexis enables access to high hydrogen concentrations referenced in hydrogen research, packaged in a portable form suitable for everyday use.<\/p>\n

Ocemida supports its products with comprehensive warranty coverage, a generous return policy, and dedicated Canadian-based customer support.<\/p>\n

The Ocemida Nexis<\/strong> is available now at ocemida.com<\/strong>.<\/p>\n

About Ocemida<\/strong><\/p>\n

Ocemida is a Canadian company advancing hydrogen water technology through engineering excellence and scientific transparency. By developing high-output, independently verified devices, Ocemida serves both everyday consumers and the research community engaged in molecular hydrogen science.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Infiniva Inc.<\/a>
Contact Person:<\/strong> John Delaney
Email:<\/strong> Send Email<\/a>
Country:<\/strong> Canada
Website:<\/strong> ocemida.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Ocemida Nexis (6000-PRO) Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers alike Ocemida, a Canadian innovator in molecular hydrogen technology, today announced that its flagship Ocemida Nexis has achieved the highest hydrogen concentration recorded by H2Hubb for … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,420,411],"tags":[],"class_list":["post-788064","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Science","category-Technology"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/788064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=788064"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/788064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=788064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=788064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=788064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}